KOSPI200 Index Rebalance Preview: Review Period Nearly Complete, Nine (Or Ten) Possible Changes
The KOSPI200 index review will be announced in the next 4 weeks. We see 9 inclusions/ exclusions and significant volume to sell on the deletions....
417 Views
KOSPI200 Index Rebalance Preview: Adds Outperform Deletes; Short Sell Ban The Wildcard
The Korea Exchange (KRX) will announce the results of the December 2020 review of the Korea Stock Exchange Kospi 200 Index (KOSPI2 INDEX) in...
451 Views
SK Biopharmaceuticals - KOSPI200 Inclusion Confirmed, Large Impact Expected
Late Friday evening, the KRX confirmed something that was widely expected. SK Biopharmaceuticals (326030 KS) meets the Fast Entry criteria for...
405 Views
Fast Entry of SK Biopharmaceuticals to KRX Indices, Incl. KOSPI 200
The KRX officially announced the fast entry of SK Biopharm to the following KRX indices in the form of Fast Entry. KOSPI 200 Fast-Entry If an IPO...
366 Views
KOSPI200 Index Rebalance Preview - Positioning Begins for December
The Korea Exchange (KRX) will announce the results of the December 2020 review of the Korea Stock Exchange Kospi 200 Index (KOSPI2 INDEX) in...
796 Views